Refine
Year of publication
- 2017 (105) (remove)
Document Type
- Article (68)
- Doctoral Thesis (32)
- Book (3)
- Contribution to a Periodical (2)
Has Fulltext
- yes (105)
Is part of the Bibliography
- no (105)
Keywords
- LTP (3)
- aging (3)
- copyright (3)
- hippocampus (3)
- piracy (3)
- publishing (3)
- Cell biology (2)
- LibGen (2)
- Photorhabdus (2)
- Sci-Hub (2)
Institute
- Biowissenschaften (105) (remove)
Hematopoietic differentiation is controlled by key transcription factors, which regulate stem cell functions and differentiation. TAL1 is a central transcription factor for hematopoietic stem cell development in the embryo and for gene regulation during erythroid/megakaryocytic differentiation. Knowledge of the target genes controlled by a given transcription factor is important to understand its contribution to normal development and disease. To uncover direct target genes of TAL1 we used high affinity streptavidin/biotin-based chromatin precipitation (Strep-CP) followed by Strep-CP on ChIP analysis using ChIP promoter arrays. We identified 451 TAL1 target genes in K562 cells. Furthermore, we analysed the regulation of one of these genes, the catalytic subunit beta of protein kinase A (PRKACB), during megakaryopoiesis of K562 and primary human CD34+ stem cell/progenitor cells. We found that TAL1 together with hematopoietic transcription factors RUNX1 and GATA1 binds to the promoter of the isoform 3 of PRKACB (Cβ3). During megakaryocytic differentiation a coactivator complex on the Cβ3 promoter, which includes WDR5 and p300, is replaced with a corepressor complex. In this manner, activating chromatin modifications are removed and expression of the PRKACB-Cβ3 isoform during megakaryocytic differentiation is reduced. Our data uncover a role of the TAL1 complex in controlling differential isoform expression of PRKACB. These results reveal a novel function of TAL1, RUNX1 and GATA1 in the transcriptional control of protein kinase A activity, with implications for cellular signalling control during differentiation and disease.
Lieblingsbild
(2017)
Dieses Bild ist wichtig, weil wir daran verstanden haben, wie in der Zelle fehlerhaftes Spleißen verhindert wird. Dazu muss man wissen, dass unsere Gene sich aus Exons und dazwischenliegenden Introns zusammensetzen. Während des Spleißens werden die Introns entfernt und die Exons in ein reifes Transkript zusammengefügt, das dann für ein Protein kodiert. Allerdings gibt es innerhalb der Introns viele Bereiche, die einem Exon sehr ähnlich sehen. Werden diese sogenannten "PseudoExons" fälschlicherweise während des Spleißprozesses erkannt und in das reife Transkript eingebaut, kann das fatale Folgen für das kodierte Protein und oft die gesamte Zelle haben. ...
Colorectal cancer (CRC) has the third highest incidence and the fourth highest mortality rate worldwide and represents a substantial health care burden and affects the life of millions of people. CRC is a genetic disease caused by the stepwise accumulation of genetic alterations. The initiating event in colorectal carcinogenesis is the aberrant activation of the WNT pathway, but other pathways are also commonly deregulated, including the PI3K/AKT pathway. A number of previous studies using genetically engineered mouse models aimed at dissecting the exact role of PI3K/AKT pathway in CRC, but have yielded in rather conflicting results. Despite the inconsistent results, these studies already put forward the idea that PI3K/AKT signaling in combination with other genetic events might substantially contribute to tumor progression. Since the PI3K/AKT pathway is frequently activated in CRC, it represents an ideal candidate for therapeutic intervention. Although extensive efforts had led to the development of numerous inhibitors targeting the PI3K/AKT pathway, the diversity of genetic alterations can challenge the identification of the most effective therapeutic targets. Therefore, the discovery of shared tumor-promoting mechanisms downstream of these genetic alterations might unravel new biomarkers and druggable targets. The aim of this study was to elucidate the precise role of PI3K/AKT pathway during the course of colorectal carcinogenesis and to decipher novel protumorigenic molecular mechanisms downstream of PI3K/AKT activation that can be used for therapeutic intervention.
To obtain a better insight into the role of the PI3K/AKT pathway during colorectal carcinogenesis, mice expressing an oncogenic variant of AKT1 (AktE17K) specifically in the intestinal epithelial cells (IEC) were used. At the age of 6 months untreated AktE17K mice showed clearly perturbed intestinal homeostasis, but no tumor formation. To induce colonic tumorigenesis, AktE17K mice were subjected to treatment with the colonic carcinogen azoxymethane (AOM). In response to AOM, AktE17K mice developed invasive but non-metastatic tumors, which showed strong nuclear accumulation of TP53. To investigate the role of PI3K/AKT signaling specifically in CRC progression, AktE17K mice were crossed to TP53-deficient mice (Tp53ΔIEC). Unlike AktE17K mice, untreated Tp53ΔIEC; AktE17K, developed highly invasive small
intestinal tumors by the age of 6 months. To investigate the role of AKT hyperactivation in colonic tumor progression, Tp53ΔIEC; AktE17K mice were subjected to AOM treatment. AKT hyperactivation significantly enhanced tumor progression and induced metastatic dissemination.
To get a better insight how AKT signaling can promote tumor progression, whole tumor tissues from AOM-treated Tp53ΔIEC and Tp53ΔIEC; AktE17K mice were subjected to next generation mRNA sequencing and phospho-proteomic analysis by mass spectrometry. Both analyses indicated that AKT hyperactivation expands the inflammatory tumor microenvironment and upregulates pathways associated with invasion and metastasis. Importantly, Gene Set Enrichment Analysis revealed that AOM-induced colon tumors of Tp53ΔIEC; AktE17K animals, are highly similar in their gene expression profile to the CMS4 subtype of human CRC, which is associated with worse overall- and relapse-free survival. Gene expression analysis also suggested elevated NOTCH signaling in the Tp53ΔIEC; AktE17K tumors. Interestingly, while the expression of Notch3 mRNA was increased in the tumors of Tp53ΔIEC; AktE17K mice, the expression of the other NOTCH receptors was unaffected by AKT hyperactivation. In vitro experiments using TP53-deficient mouse tumor organoids with hyperactive AKT signaling confirmed the direct, tumor cell-intrinsic link between AKT activation and increased Notch3 expression. Moreover, inhibition of EZH2 mimicked the effect of AKT hyperactivation on Notch3 expression, suggesting that AKT regulates Notch3 via an epigenetic mechanism.
Knock-down of Notch3 in TP53-deficient mouse tumor organoids with hyperactive AKT signaling resulted in differential regulation of several pathways with potential role in invasion and metastasis and in cell death and survival. Subsequent in vivo experiments confirmed the role of NOTCH3 signaling in CRC progression. Treatment of AOM-induced Tp53ΔIEC; AktE17K mice with a NOTCH3 antagonistic antibody or the γ-secretase inhibitor DAPT significantly reduced invasion and metastasis. Importantly, NOTCH3 expression was also found to be associated with human CRC progression, suggesting that NOTCH3 represent a valid target for the treatment of CRC. This work, using genetically engineered mouse models and advanced in vitro techniques, has demonstrated a strong tumor promoting role for PI3K/AKT signaling in CRC progression and has identified NOTCH3 signaling as a potential therapeutic target downstream of the PI3K/AKT pathway.
Colorectal cancer (CRC) has the third highest incidence and the fourth highest mortality rate worldwide and represents a substantial health care burden and affects the life of millions of people. CRC is a genetic disease caused by the stepwise accumulation of genetic alterations. The initiating event in colorectal carcinogenesis is the aberrant activation of the WNT pathway, but other pathways are also commonly deregulated, including the PI3K/AKT pathway. A number of previous studies using genetically engineered mouse models aimed at dissecting the exact role of PI3K/AKT pathway in CRC, but have yielded in rather conflicting results. Despite the inconsistent results, these studies already put forward the idea that PI3K/AKT signaling in combination with other genetic events might substantially contribute to tumor progression.
Since the PI3K/AKT pathway is frequently activated in CRC, it represents an ideal candidate for therapeutic intervention. Although extensive efforts had led to the development of numerous inhibitors targeting the PI3K/AKT pathway, the diversity of genetic alterations can challenge the identification of the most effective therapeutic targets. Therefore, the discovery of shared tumor-promoting mechanisms downstream of these genetic alterations might unravel new biomarkers and druggable targets. The aim of this study was to elucidate the precise role of PI3K/AKT pathway during the course of colorectal carcinogenesis and to decipher novel pro-tumorigenic molecular mechanisms downstream of PI3K/AKT activation that can be used for therapeutic intervention.
To obtain a better insight into the role of the PI3K/AKT pathway during colorectal carcinogenesis, mice expressing an oncogenic variant of AKT1 (AktE17K) specifically in the intestinal epithelial cells (IEC) were used. At the age of 6 months untreated AktE17K mice showed clearly perturbed intestinal homeostasis, but no tumor formation. To induce colonic tumorigenesis, AktE17K mice were subjected to treatment with the colonic carcinogen azoxymethane (AOM). In response to AOM, AktE17K mice developed invasive but nonmetastatic tumors, which showed strong nuclear accumulation of TP53. To investigate the role of PI3K/AKT signaling specifically in CRC progression, AktE17K mice were crossed to TP53- deficient mice (Tp53ΔIEC). Unlike AktE17K mice, untreated Tp53ΔIECAktE17K, developed highly invasive small intestinal tumors by the age of 6 months. To investigate the role of AKT hyperactivation in colonic tumor progression, Tp53ΔIECAktE17K mice were subjected to AOM treatment. AKT hyperactivation significantly enhanced tumor progression and induced metastatic dissemination.
To get a better insight how AKT signaling can promote tumor progression, whole tumor tissues from AOM-treated Tp53ΔIEC and Tp53ΔIECAktE17K mice were subjected to next generation mRNA sequencing and phospho-proteomic analysis by mass spectrometry. Both analyses indicated that AKT hyperactivation expands the inflammatory tumor microenvironment and upregulates pathways associated with invasion and metastasis. Importantly, Gene Set Enrichment Analysis revealed that AOM-induced colon tumors of Tp53ΔIECAktE17K animals, are highly similar in their gene expression profile to the CMS4 subtype of human CRC, which is associated with worse overall- and relapse-free survival7 . Gene expression analysis also suggested elevated NOTCH signaling in the Tp53ΔIECAktE17K tumors. Interestingly, while the expression of Notch3 mRNA was increased in the tumors of Tp53ΔIECAktE17K mice, the expression of the other NOTCH receptors was unaffected by AKT hyperactivation. In vitro experiments using TP53-deficient mouse tumor organoids with hyperactive AKT signaling confirmed the direct, tumor cell-intrinsic link between AKT activation and increased Notch3 expression. Moreover, inhibition of EZH2 mimicked the effect of AKT hyperactivation on Notch3 expression, suggesting that AKT regulates Notch3 via an epigenetic mechanism.
Knock-down of Notch3 in TP53-deficient mouse tumor organoids with hyperactive AKT signaling resulted in differential regulation of several pathways with potential role in invasion and metastasis and in cell death and survival. Subsequent in vivo experiments confirmed the role of NOTCH3 signaling in CRC progression. Treatment of AOM-induced Tp53ΔIECAkt E17K mice with a NOTCH3 antagonistic antibody or the γ-secretase inhibitor DAPT significantly reduced invasion and metastasis. Importantly, NOTCH3 expression was also found to be associated with human CRC progression, suggesting that NOTCH3 represent a valid target for the treatment of CRC. This work, using genetically engineered mouse models and advanced in vitro techniques, has demonstrated a strong tumor promoting role for PI3K/AKT signaling in CRC progression and has identified NOTCH3 signaling as a potential therapeutic target downstream of the PI3K/AKT pathway.
Ziel dieser Dissertation war es, die biologische Rolle der Autophagie für die Entwicklung, Alterung und mitochondriale Qualitätskontrolle in dem Ascomyceten Podospora anserina zu untersuchen. Folgende Ergebnisse wurden dabei erzielt:
1. Der Verlust einer funktionalen Autophagie-Maschinerie ist in P. anserina mit einem Defekt der Sporen-Entwicklung bzw. -Keimung charakterisiert.
2. Es konnten drei Methoden zur Untersuchung der Autophagie in P. anserina etabliert werden: 1) Die Verwendung eines Gfp::PaAtg8-Stamms ermöglicht die Fluoreszenzmikroskopische Bestimmung der Autophagosomen-Anzahl; 2) Die phänotypische Charakterisierung des PaAtg1-Deletionsstamms unter verschiedenen Stressbedingungen (z. B. Stickstoffmangel, Rapamycin) liefert Hinweise auf eine mögliche Autophagie-abhängige Stressadaption; 3) Die Verwendung des „GFPcleavage assays“ ermöglicht einen quantitativen Nachweis genereller und selektiver Autophagie (hier: Mitophagie).
3. In zwei voneinander unabhängigen Experimenten wurde ein altersabhängiger Anstieg der Autophagie für P. anserina demonstriert: Das Autophagie-Niveau nimmt in gealterten P. anserina-Kulturen zu. Gleichzeitig resultiert der Verlust der Autophagie in ∆PaAtg1 in eine reduzierte Lebensspanne. Unter Stressbedingungen (hier: Stickstoffmangel) wird dieser positive Einfluss der Autophagie auf die Lebensspanne im Wildtyp sogar noch verstärkt.
4. Der unerwartet „gesunde“ Phänotyp der PaSod3-Deletionsmutante ist abhängig von einer funktionalen Autophagie-Maschinerie. Der Mitophagie wurde eine besondere Rolle als Kompensationsmechanismus für den Verlust von PaSOD3 zugeteilt, da das Mitophagie-Niveau in dieser Mutante erhöht ist. Am Beispiel dieser Mutante, für die ein erhöhter Superoxid-Ausstoß nachgewiesen wurde, konnte eine Dosis-abhängige Wirkung von ROS in P. anserina identifiziert werden. Eine geringe zelluläre ROSMenge verursacht eine mitohormetische Reaktion, die eine Induktion der Mitophagie zur Folge hat und sich positiv auf den Organismus auswirkt. Übersteigt die zelluläre ROS-Dosis einen kritischen Punkt, kommt es zur Induktion des autophagischen Zelltods und damit zum vorzeitigen Tod des Individuums.
5. Der Verlust der PaCLPXP-Protease führt zu Beeinträchtigungen in der Funktion und Zusammensetzung der mitochondrialen Atmungskette. Dieses Defizit im Energiemetabolismus wird über eine Induktion der AOX, vor allem aber über eine ZUSAMMENFASSUNG 127 gesteigerte Autophagie kompensiert. Die deutlich verlängerte Lebensspanne der verschiedenen PaClpXP-Deletionsmutanten (∆PaClpX, ∆PaClpP und ∆PaClpXP) ist abhängig von einer funktionalen Autophagie-Maschinerie. Interessanterweise konnte keine kompensatorische Funktion der Autophagie oder Mitophagie für den Verlust der mitochondrialen i-AAA-Protease PaIAP in P. anserina nachgewiesen werden.
Autophagie/Mitophagie stellt einen übergeordneten Qualitätskontrollmechanismus in P. anserina dar, der den Organismus sehr effektiv vor zellulären Schäden und Dysfunktionen bewahrt und einen positiven Einfluss auf die Alterung, Entwicklung und Energieversorgung einnimmt.
Tissue integrity is defined by the composition and connection of cells as a structural and functional unit. It is modulated by a magnitude of processes including differentiation, survival, controlled death and adhesion of cells. Besides, external factors such as physical forces are also involved. A suitable model system to study all modalities of tissue integrity is the mammary gland. Postnatally and within the reproductive phase, the mammary gland undergoes morphological and functional modifications that periodically loosen or strengthen tissue integrity. An important point in the development of the mammary gland is the regression during weaning, also termed involution. The transition from lactation to involution is important for a controlled loss of tissue integrity. In this transition, collective cell death is initiated but not yet prominent enabling the mammary gland to fully recover lactation.
In this thesis, modalities of tissue integrity were investigated using three-dimensional cell cultures (i.e. spheroids) and the mammary gland as model systems. In the context of this thesis, I established (1) an immunofluorescence staining protocol and its detailed evaluation. Furthermore, I studied (2) the role of cell survival during mammary gland development, (3) the effect of physical forces that modulate tissue integrity and (4) the contribution of proteins to cell adhesion and growth.
Since a homogeneous fluorescence stain of the specimen is necessary for quantitative analysis, an immunofluorescence staining protocol was established to stain large spheroids in toto. The evaluation contributes qualitative and quantitative criteria that judge the specificity, intensity and homogeneity of the stain. Based on this approach, it was possible to demonstrate the morphological and functional characteristics that spheroids share with the mammary gland in vivo. These characteristics included the synthesis of extracellular matrix, the development of polarized acinar structures and lactogenic differentiation.
The role of cell survival during mammary gland development was analyzed by means of the expression profile of the pro-survival protein BAG3. The expression of BAG3 differed in the progress of mammary gland development. While the expression was low during pregnancy, it rose in the lactation phase and peaked within the first days of involution, indicating that BAG3 is associated with early involution in the mammary gland. In vitro experiments related the expression of BAG3 to cell survival in mammary epithelial cells.
Physical forces naturally occur during developmental processes influence tissue integrity during the initiation of mammary gland involution. The influence of physical force applied as compression on mammary epithelial spheroids was investigated. A morphological analysis showed that following a lag, the cell nuclei volume changed upon compression. A short-term compression induced the activation of caspases. A prolonged compression reduced the activity of caspases. This suggests the induction of a process that allows cells the adaption to changing environmental conditions. BAG3 is known to be involved in mechanical stress-induced autophagy, also known as chaperone assisted selective autophagy (CASA). Compression of spheroids did not induce CASA. The experimentally applied strain was not comparable to the strain found in the alveolar cells during involution in vivo. Thus, whether or not CASA is activated during mammary gland involution remains elusive. Nevertheless, the methodical approach to apply compression on spheroids in vitro is a model to study the influence of physical forces on cell aggregates.
Apart from cell survival and physical forces, growth and adhesion of cells affect tissue integrity. A spheroid formation assay and subsequent data analysis and computational modeling enabled the investigation of these processes in a non-adhesive environment. The analysis suggested that spheroid formation follows a reaction-controlled process, in which cells do not necessarily form a connection when they collide. The loss of function of either E-cadherin or actin strongly inhibited the formation of a spheroid. The analysis further revealed that neither E-cadherin nor actin influence the chance of the cells to form a connection when they collide. Both molecules are more important in stabilizing established connections. Depolymerization of microtubules still allowed spheroids to form, but the formation was decelerated and growth of the final spheroids was inhibited. The results from computational modeling suggested that microtubules act on cell adhesion through different mechanisms, which also vary among different cell types. The inhibition of FAK phosphorylation at Y397, a downstream target of integrin signaling, and the analysis of FAK protein levels in spheroids showed that integrin-mediated signaling is not prominent in three-dimensional spheroids formed from non-invasive cells. A deletion of BAG3 gene expression increased the number of dead cells in forming spheroids suggesting that BAG3 predominantly affects cell survival.
The results of this thesis identified and characterized adhesion- and survival-associated proteins that are important for tissue integrity. This thesis suggests that a BAG3-dependent cell survival mechanism is prominent at the beginning of mammary gland involution. Future studies will have to identify the related factors and inducers of tissue integrity loss in the mammary gland. This will shed light on the physiology of the organ and could explain the disorders that destroy its integrity. In addition, this thesis contributes to a better understanding of spontaneous cell aggregation, the aggregate organization and implies a role of cell migration in these processes. Future studies that focus on three-dimensional cell migration could explain, how cell migration is promoted and to which extent it supports tissue integrity.
Box C/D snoRNAs are known to guide site-specific ribose methylation of ribosomal RNA. Here, we demonstrate a novel and unexpected role for box C/D snoRNAs in guiding 18S rRNA acetylation in yeast. Our results demonstrate, for the first time, that the acetylation of two cytosine residues in 18S rRNA catalyzed by Kre33 is guided by two orphan box C/D snoRNAs–snR4 and snR45 –not known to be involved in methylation in yeast. We identified Kre33 binding sites on these snoRNAs as well as on the 18S rRNA, and demonstrate that both snR4 and snR45 establish extended bipartite complementarity around the cytosines targeted for acetylation, similar to pseudouridylation pocket formation by the H/ACA snoRNPs. We show that base pairing between these snoRNAs and 18S rRNA requires the putative helicase activity of Kre33, which is also needed to aid early pre-rRNA processing. Compared to yeast, the number of orphan box C/D snoRNAs in higher eukaryotes is much larger and we hypothesize that several of these may be involved in base-modifications.
Cardiovascular disease is the leading cause of death worldwide. Aging is among the greatest risk factors for cardiovascular disease. Cardiovascular disease comprises several diseases, for example myocardial infarction, elevated blood pressure and stroke. Many processes are known to promote or worsen cardiovascular disease and in the present study, cellular senescence and inflammatory activation were of special interest, as they have a strong association to aging and can be seen as hallmarks of cellular aging.
Long noncoding RNAs (lncRNAs) are noncoding RNAs with a length of more than 200 nucleotides. In recent years, numerous regulatory functions were shown for these transcripts and lncRNAs were shown to directly interact with DNA, RNA and proteins. The long noncoding RNA H19 was among the first described noncoding RNAs and was initially shown to act as a tumor suppressor. More recently, several studies showed oncogenic roles for H19. In regards to the cardiovascular system, H19 was not analyzed before.
We show that H19 is the most profoundly downregulated lncRNA in endothelial cells of aged mice compared to young littermates. Microarray analysis of human primary endothelial cells upon pharmacological H19 depletion revealed an involvement of H19 in cell cycle regulation. Loss of H19 in human endothelial cells in vitro led to reduced proliferation and to increased senescence. H19 depletion was shown to counteract proliferation before, but none of the described mechanisms applied to endothelial cells. We show that the reduction in proliferative capacity and the pro-senescent function of H19 is most probably mediated by an upregulation of p16ink4A and p21 upon H19 depletion.
When we compared the angiogenic capacity of aortic endothelial cells from young and aged mice in an aortic ring assay, rings from aged mice showed a reduced cumulative sprout length. Interestingly, pharmacological inhibition of H19 in aortic rings of young animals, where H19 is highly expressed, was sufficient to reduce the cumulative sprout length to levels we observed from aged animals. Furthermore, overexpression of human H19 in aortic rings of aged mice, where H19 is poorly expressed, rescued the impaired angiogenic capacity of aged endothelial cells.
We generated inducible endothelial-specific H19 knockout mice (H19iEC-KO) and subjected these animals to hind limb ischemia surgery followed by perfusion analysis in the hind limbs by laser-doppler velocimetry and histological analysis. Perfusion in the operated hind limb was increased in H19iEC-KO compared to Ctrl littermates, which was in contrast to a reduction in capillary density in the operated hind limbs of H19iEC-KO animals compared to Ctrl littermates and to our previous results. Analysis of arteriogenesis revealed an increase in collateral growth upon EC-specific H19 depletion in the ischemic hind limbs, which explains the increase in perfusion despite the reduction in capillary density. Further characterization of the animals revealed an increase in leukocyte infiltration into the tissue in the ischemic hind limbs upon endothelial-specific H19 depletion, indicating a potential role of H19 in inflammatory tissue activation.
Reanalysis of the microarray data from human primary endothelial cells upon H19 depletion revealed an association of H19 with inflammatory signaling and more specifically with IL-6/JAK2/STAT3 signaling. Analysis of cell surface adhesion molecule expression revealed an upregulation of ICAM-1 and VCAM-1 on mRNA level and an increase of the abundance of the two proteins on the cell surface of human primary endothelial cells. Consequently, adhesion of isolated human monocytes to human primary endothelial cells was increased upon H19 depletion in vitro. Interestingly, TNF-α mediated inflammatory activation of primary human endothelial cells repressed H19 expression. H19 did not function via previously described mechanisms. We excluded a competitive endogenous RNA (ceRNA) function for H19 in endothelial cells and showed that miR-675, which is processed from H19, does not play a role in the endothelium. Furthermore, H19 did not regulate previously described genes or pathways.
Analysis of transcription factor activity upon H19 depletion and overexpression revealed a differential activity of STAT3. STAT3 phosphorylation at TYR705 and thus activation was increased upon H19 depletion. Inhibition of STAT3 activation using a small compound inhibitor abolished the effects of H19 depletion on mRNA expression of p21, ICAM-1 and VCAM-1 and on proliferation, indicating that the effects of H19 are at least partially mediated via STAT3. STAT3 was shown to have positive effects on the cardiovascular system before, most likely due to upregulation of VEGF in a STAT3-dependent manner. We were not able to confirm previously described mechanisms for STAT3 in the present study and propose a new mechanism of action for the H19-dependent regulation of STAT3. Taken together, these results identify the long noncoding RNA H19 as a pivotal regulator of endothelial cell function. Figure 38 summarizes the described functions of H19 in endothelial cells.
Two theories address the origin of repeating patterns, such as hair follicles, limb digits, and intestinal villi, during development. The Turing reaction–diffusion system posits that interacting diffusible signals produced by static cells first define a prepattern that then induces cell rearrangements to produce an anatomical structure. The second theory, that of mesenchymal self-organisation, proposes that mobile cells can form periodic patterns of cell aggregates directly, without reference to any prepattern. Early hair follicle development is characterised by the rapid appearance of periodic arrangements of altered gene expression in the epidermis and prominent clustering of the adjacent dermal mesenchymal cells. We assess the contributions and interplay between reaction–diffusion and mesenchymal self-organisation processes in hair follicle patterning, identifying a network of fibroblast growth factor (FGF), wingless-related integration site (WNT), and bone morphogenetic protein (BMP) signalling interactions capable of spontaneously producing a periodic pattern. Using time-lapse imaging, we find that mesenchymal cell condensation at hair follicles is locally directed by an epidermal prepattern. However, imposing this prepattern’s condition of high FGF and low BMP activity across the entire skin reveals a latent dermal capacity to undergo spatially patterned self-organisation in the absence of epithelial direction. This mesenchymal self-organisation relies on restricted transforming growth factor (TGF) β signalling, which serves to drive chemotactic mesenchymal patterning when reaction–diffusion patterning is suppressed, but, in normal conditions, facilitates cell movement to locally prepatterned sources of FGF. This work illustrates a hierarchy of periodic patterning modes operating in organogenesis.